Derisking Early Research and Increasing Likelihood of Clinical Success

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Is there a secret recipe for successful partnerships between founders and their investment partners that can maximize value of their assets and improve the odds for clinical success? Join this panel of leading translational and development experts from the start-up ecosystem that looks beyond capital investment for start-ups. These collaborative models work to deliver significant added value to early and translational research efforts through active, operational partnerships focused on driving a program forward. Learn how they engage with portfolio companies to grow their knowledge base, develop realistic clinical programs, manage expectations and enable development of commercially viable pharma and biotech assets.
Moderator
photo
Managing Editor, US Commercial News
Scrip/The Pink Sheet
Speakers
photo
Chairman & CEO
Xontogeny
photo
Chief Operating Officer
Deerfield Management | Deerfield Discovery and Development Company (3DC)
photo
Partner, University Relations
Osage University Partners
photo
Head, Johnson & Johnson Innovation, East North America
Johnson & Johnson Innovation